name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
1X2R_A_B_75_1.pdb,1X2R,16507366,1.70,Q9Z2X8,PF01344,2.120.10.80,A,290,B,9,L-----------DEETGEFL-----,C-----------TTTTTCCC-----,2-----------12000033-----,75,1,4,e-----------CCCCCCee-----,6,2,A:0;F:0;N:0;Q:0;R:0;S:0;Y:0,A:0;F:0;N:0;Q:0;R:1;S:0;Y:0,C:2;D:2;E:4;G:2;H:2;M:3;N:2;P:2;Q:3;R:5;S:1;T:2;V:1,A:17;C:7;D:13;E:10;F:3;G:33;H:8;I:11;K:1;L:21;M:5;N:12;P:11;Q:2;R:13;S:18;T:14;V:26;W:6;Y:14,B:0;E:0;T:0,B:0;E:1;T:0,C:2;E:6;G:4;T:19,B:4;C:48;E:128;G:2;T:63,75_1,A:1;F:1;N:1;Q:1;R:2;S:4;Y:3,B:10;E:1;T:2,A:0;F:0;N:0;Q:0;R:0;S:0;Y:0,B:0;E:0;T:0,8-----------66545579-----,ALA_233_A_COREBINDING;ARG_160_A_COREBINDING;ARG_57_A_exosite;ARG_92_A_COREBINDING;ASN_59_A_COREBINDING;GLN_207_A_COREBINDING;PHE_254_A_COREBINDING;SER_185_A_COREBINDING;SER_232_A_COREBINDING;SER_279_A_COREBINDING;SER_40_A_COREBINDING;TYR_11_A_COREBINDING;TYR_202_A_COREBINDING;TYR_249_A_COREBINDING,LDEETGEFL,0.988645542093818,0.405172413793103,4.50164292231181,9-----------99999999-----,LEU_1_B_e;ASP_2_B_C;GLU_3_B_C;GLU_4_B_C;THR_5_B_C;GLY_6_B_C;GLU_7_B_C;PHE_8_B_e;LEU_9_B_e,"STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER 2 SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON 3 NRF2"
2DYH_A_B_75_1.pdb,2DYH,17785452,1.90,Q9Z2X8,PF01344,2.120.10.80,A,296,B,6,-----------WR-QDID-------,-----------CG-GGCC-------,-----------32-0002-------,75,1,4,-----------eC-CCCC-------,5,1,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,C:2;D:3;E:4;G:2;H:2;L:2;M:3;N:3;P:2;Q:4;R:7;S:1;T:2;V:1,A:17;C:7;D:13;E:10;F:3;G:31;H:8;I:12;K:2;L:19;M:5;N:11;P:11;Q:3;R:13;S:19;T:14;V:26;W:6;Y:14,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:6;E:6;G:5;T:21,B:9;C:51;E:130;G:4;T:50,75_1,A:1;F:1;G:2;N:1;Q:1;R:2;S:3;Y:3,B:9;C:1;E:1;T:3,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,B:0;C:0;E:0;T:0,-----------88-7678-------,ALA_233_A_COREBINDING;ARG_160_A_COREBINDING;ARG_92_A_COREBINDING;ASN_59_A_COREBINDING;GLN_207_A_COREBINDING;GLY_251_A_COREBINDING;GLY_280_A_COREBINDING;PHE_254_A_COREBINDING;SER_185_A_COREBINDING;SER_232_A_COREBINDING;SER_279_A_COREBINDING;TYR_11_A_COREBINDING;TYR_202_A_COREBINDING;TYR_249_A_COREBINDING,ILWRQDIDLGVSREV,0.974099099099099,0.396959459459459,2.59158677261634,-----------99-9999-------,TRP_1_B_e;ARG_2_B_C;GLN_3_B_C;ASP_4_B_C;ILE_5_B_C;ASP_6_B_C,"CRYSTAL STRUCTURE OF THE KEAP1 PROTEIN IN COMPLEXED WITH 2 THE NTERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR"
2Z32_A_B_75_1.pdb,2Z32,18391415,2.00,Q9Z2X8,PF01344,2.120.10.80,A,290,B,9,Q-----------NEENGEQE-----,C-----------TTTTTCCC-----,2-----------11000024-----,75,1,4,e-----------CCCCCCee-----,6,2,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,C:2;D:3;E:4;G:2;H:2;L:2;M:3;N:3;P:2;Q:2;R:7;S:2;T:4;V:1,A:17;C:7;D:12;E:10;F:2;G:32;H:8;I:11;K:1;L:19;M:5;N:11;P:11;Q:3;R:11;S:17;T:12;V:26;W:6;Y:14,B:0;E:0;T:0,B:0;E:0;T:0,C:4;E:7;G:5;T:23,B:9;C:50;E:125;G:4;T:47,75_1,A:1;F:2;G:1;N:1;Q:1;R:3;S:4;Y:3,B:11;E:2;T:3,A:0;F:0;G:0;N:0;Q:0;R:0;S:0;Y:0,B:0;E:0;T:0,9-----------87666789-----,ALA_233_A_COREBINDING;ARG_160_A_COREBINDING;ARG_57_A_COREBINDING;ARG_92_A_COREBINDING;ASN_59_A_COREBINDING;GLN_207_A_COREBINDING;GLY_251_A_COREBINDING;PHE_155_A_COREBINDING;PHE_254_A_COREBINDING;SER_185_A_COREBINDING;SER_232_A_COREBINDING;SER_279_A_COREBINDING;SER_40_A_COREBINDING;TYR_11_A_COREBINDING;TYR_202_A_COREBINDING;TYR_249_A_COREBINDING,AQNEENGEQEADNEVD,0.988645542093818,0.405172413793103,5.16657042921124,9-----------99999999-----,GLN_1_B_e;ASN_2_B_C;GLU_3_B_C;GLU_4_B_C;ASN_5_B_C;GLY_6_B_C;GLU_7_B_C;GLN_8_B_e;GLU_9_B_e,"CRYSTAL STRUCTURE OF KEAP1 COMPLEXED WITH PROTHYMOSIN ALPHA"
3WN7_L_M_75_1.pdb,3WN7,24366543,1.57,Q9Z2X8,PF01344,2.120.10.80,L,286,M,23,-MDLIDILWRQDI-DLGVSREVFDS,-CCHHHHHHHHCG-GGCCCGGGGCC,-322101011001-00001131026,75,1,4,-EEEEEEEEDDDC-CCCCEEEEEEE,5,11,A:0;C:0;F:0;G:0;H:0;I:0;N:0;R:0;S:0;Y:0,A:0;C:0;F:0;G:0;H:0;I:0;N:0;R:0;S:0;Y:0,D:3;E:4;G:1;H:2;L:2;M:2;N:2;P:2;Q:2;R:6;S:1;T:2;V:1,A:17;C:7;D:12;E:9;F:3;G:30;H:7;I:9;K:1;L:19;M:5;N:10;P:10;Q:4;R:12;S:17;T:14;V:26;W:6;Y:14,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:2;E:5;G:4;T:19,B:5;C:52;E:119;G:2;T:54,75_1,A:1;C:0;F:1;G:3;H:0;I:0;N:1;R:2;S:4;Y:3,B:9;C:1;E:1;T:4,A:0;C:1;F:0;G:1;H:1;I:2;N:2;R:1;S:1;Y:0,B:2;C:0;E:5;T:2,-965665445445-54556678799,ALA_233_L_COREBINDING;ARG_160_L_COREBINDING;ARG_57_L_EXOSITE;ARG_92_L_COREBINDING;ASN_59_L_COREBINDING;ASN_64_L_EXOSITE;ASN_91_L_EXOSITE;CYS_111_L_EXOSITE;GLY_110_L_EXOSITE;GLY_186_L_COREBINDING;GLY_280_L_COREBINDING;GLY_41_L_COREBINDING;HIS_113_L_EXOSITE;ILE_112_L_EXOSITE;ILE_138_L_EXOSITE;PHE_254_L_COREBINDING;SER_108_L_EXOSITE;SER_185_L_COREBINDING;SER_232_L_COREBINDING;SER_279_L_COREBINDING;SER_40_L_COREBINDING;TYR_11_L_COREBINDING;TYR_202_L_COREBINDING;TYR_249_L_COREBINDING,MDLIDILWRQDIDLGVSREVFDFSQRQKDYELEKQ,0.978417210313762,0.410839160839161,1.86257724672025,-999999995999-99999999999,MET_1_M_E;ASP_2_M_E;LEU_3_M_E;ILE_4_M_E;ASP_5_M_E;ILE_6_M_E;LEU_7_M_E;TRP_8_M_E;ARG_9_M_E;GLN_10_M_E;ASP_11_M_E;ILE_12_M_C;ASP_13_M_C;LEU_14_M_C;GLY_15_M_C;VAL_16_M_C;SER_17_M_E;ARG_18_M_E;GLU_19_M_E;VAL_20_M_E;PHE_21_M_E;ASP_22_M_E;SER_24_M_E,"CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE NTERMINAL REGION OF 2 THE NRF2 TRANSCRIPTION FACTOR"
4CH9_A_C_75_2.pdb,4CH9,24641320,1.84,Q9UH77,PF01344,2.120.10.80,A,286,C,9,EPEEPEADQ-,CCCCCGGGC-,322200012-,75,2,2,CCCCCCCCC-,9,0,F:0;G:0;H:0;R:0;S:0;T:0;Y:0,F:0;G:0;H:0;R:0;S:0;T:0;Y:0,A:3;D:1;E:3;F:1;G:1;K:6;N:2;P:5;Q:1;R:1;S:6;T:1;V:2,A:22;C:6;D:15;E:9;F:3;G:29;H:2;I:6;K:3;L:17;M:8;N:11;P:4;Q:7;R:14;S:12;T:13;V:35;W:6;Y:14,B:0;E:0;T:0,B:0;E:0;T:0,C:4;E:4;G:2;T:23,B:9;C:46;E:123;G:1;T:57,75_2,F:2;G:4;H:1;R:3;S:3;T:2;Y:2,B:7;E:2;T:8,F:0;G:0;H:0;R:0;S:0;T:0;Y:0,B:0;E:0;T:0,975543355-,ARG_229_A_COREBINDING;ARG_40_A_COREBINDING;ARG_61_A_COREBINDING;GLY_105_A_COREBINDING;GLY_108_A_COREBINDING;GLY_152_A_COREBINDING;GLY_58_A_COREBINDING;HIS_199_A_COREBINDING;PHE_103_A_COREBINDING;PHE_56_A_COREBINDING;SER_106_A_COREBINDING;SER_133_A_COREBINDING;SER_182_A_COREBINDING;THR_107_A_COREBINDING;THR_87_A_COREBINDING;TYR_150_A_COREBINDING;TYR_278_A_COREBINDING,EPEEPEADQHQ,0.839160839160839,0.399371574371574,,999999999-,GLU_1_C_C;PRO_2_C_C;GLU_3_C_C;GLU_4_C_C;PRO_5_C_C;GLU_6_C_C;ALA_7_C_C;ASP_8_C_C;GLN_9_C_C,"CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN 2 COMPLEX WITH A WNK4 PEPTIDE"
4CHB_B_D_75_2.pdb,4CHB,24641320,1.56,O95198,PF01344,2.120.10.80,B,286,D,10,EPEEPEADQH,CCCCCGGGCC,3222000015,75,2,2,CCCCCCCCCe,9,1,F:0;G:0;H:0;K:0;R:0;S:0;T:0;V:0;Y:0,F:0;G:0;H:0;K:0;R:0;S:0;T:0;V:0;Y:0,A:2;C:1;D:1;E:2;G:1;K:5;L:1;N:4;P:4;R:5;S:7;T:6;V:1,A:22;C:7;D:13;E:9;F:3;G:28;H:2;I:4;K:2;L:18;M:9;N:12;P:4;Q:5;R:12;S:13;T:9;V:37;W:6;Y:13,B:0;E:0;G:0;T:0,B:0;E:0;G:0;T:0,C:6;E:8;G:1;T:25,B:9;C:40;E:120;G:1;T:58,75_2,F:2;G:3;H:1;K:1;R:3;S:3;T:2;V:1;Y:2,B:7;E:2;G:1;T:8,F:0;G:0;H:0;K:0;R:0;S:0;T:0;V:0;Y:0,B:0;E:0;G:0;T:0,9875444469,ARG_229_B_COREBINDING;ARG_40_B_COREBINDING;ARG_61_B_COREBINDING;GLY_105_B_COREBINDING;GLY_108_B_COREBINDING;GLY_58_B_COREBINDING;HIS_199_B_COREBINDING;LYS_13_B_COREBINDING;PHE_103_B_COREBINDING;PHE_56_B_COREBINDING;SER_133_B_COREBINDING;SER_134_B_COREBINDING;SER_182_B_COREBINDING;THR_107_B_COREBINDING;THR_87_B_COREBINDING;TYR_150_B_COREBINDING;TYR_278_B_COREBINDING;VAL_152_B_COREBINDING,EPEEPEADQHQ,0.839160839160839,0.409700149570839,6.03166361794157,9999999999,GLU_1_D_C;PRO_2_D_C;GLU_3_D_C;GLU_4_D_C;PRO_5_D_C;GLU_6_D_C;ALA_7_D_C;ASP_8_D_C;GLN_9_D_C;HIS_10_D_e,"CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN 2 COMPLEX WITH A WNK4 PEPTIDE"
